384 results on '"Fujiwara, Y."'
Search Results
2. Effective detection of variable celestial objects using machine learning-based periodic analysis
3. Pole position of Λ(1405) measured in d(K−,n)πΣ reactions
4. 696P Geriatric nutritional risk index as a prognostic factor in elderly patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with cisplatin
5. EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors
6. EP08.02-118 TRUST-II: A Global Phase II Study for Taletrectinib inROS1fusion Positive Lung Cancer and Other Solid Tumors
7. 77TiP TRUST-II: A global phase II study for taletrectinib in ROS1 fusion-positive lung cancer and other solid tumors
8. A Case of Primary B-Cell Lymphoma of the Gallbladder
9. 574P Clinical impact of the GAPP score and SDHB negativity in patients with pheochromocytoma/paraganglioma
10. 1521O A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-threatening unmet medical needs (NCCH1806/MK004)
11. 1292P Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)
12. 1249P Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
13. POS-161 A CASE OF EGPA THAT DEVELOPED DURING REMISSION OF IGA NEPHROPATHY
14. P09.19 Health Disparities Characteristics in Cancer Survivorships among Sexual Minorities in the US - A Cross-Sectional Study Using BRFSS 2018 Data
15. MA04.02 Lung Cancer Screening Utilization and Its Correlates in Sexual Minorities: An Analysis of the BRFSS 2018
16. P41.01 Disparities in Lung Cancer Screening by Baseline Comorbidities: An Analysis of the Behavioral Risk Factor Surveillance System Survey 2018
17. The novel index using c-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer
18. Strategy of therapies in recurrence type of pancreatic cancer after surgery
19. 245P Clinicopathological features including response to platinum-based chemotherapy in endometrial carcinomas involving SWI/SNF complex inactivation
20. Down-grading of ipsilateral hydronephrosis by neoadjuvant chemotherapy is associated with better oncological outcomes after radical nephroureterectomy in patients with ureteral cancer
21. Promoting a medical system for renal transplantation in the remote island in Japan
22. 17O A first-in-human phase I study of MORAb-202 in patients with folate receptor alpha-positive advanced solid tumors
23. SUN-415 THROMBOTIC MICROANGIOPATHY AFTER STEROID PULSE THERAPY IN A RAPIDLY-PROGRESSIVE GLOMERULONEPHRITIS CASE HAVING HIGH -TITER ANTI-GBM ANTIBODY AND MPO-ANCA
24. A platform trial with a registry study for rare cancers: MASTER KEY project
25. P2.14-23 Initial Analysis in NSCLC Part of Randomized Trial Evaluating Topical Corticosteroid for the Facial Acneiform Rash by EGFR Inhibitors
26. Phase I study of liposomal formulation of eribulin (E7389-LF) in patients (pts) with advanced solid tumours: Primary results of dose-escalation part
27. P1.01-102 Actionable Gene Aberration and the Response of Matched Therapy Among Patients with Non-Small-Cell Lung Carcinoma
28. Radiographic characteristics and poor prognostic factors of interstitial lung disease (ILD) in nivolumab-treated patients with non-small cell lung cancer (NSCLC)
29. A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, a disease with a high unmet need
30. Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study
31. Correlation between folate receptor alpha (FRα) expression and clinicopathological features in lung adenocarcinoma
32. “K−pp”, a K‾-meson nuclear bound state, observed in 3He(K−,Λp)n reactions
33. Dynamic change in the distribution of cancer types in oncology phase I trials
34. P050 Long-Term Survival of Stage IIIA-N2 NSCLC Patients with Interstitial Lung Diseases
35. Formation and optical properties of Tm,Yb-codoped ZnO nanowires grown by sputtering-assisted metalorganic chemical vapor deposition
36. OA04 Factors Influencing the Non-Administration of Chemotherapies in Patients Who Progressed After First-Line EGFR-TKIs
37. Effect of Systematic Conversion to Generic Mycophenolate Mofetil (MMF) in Kidney Transplantation: A Single-Center Clinical Experience from Japan
38. P023 Factors Associated With Administration of Subsequent Cytotoxic Chemotherapy after Nivolumab in Patients With Advanced NSCLC
39. P080 Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients with Advanced NSCLC
40. A phase I trial of the safety and pharmacokinetics of cemiplimab, a human monoclonal antibody to programmed death-1, in Japanese patients with advanced malignancies, including expansion cohorts for patients with non-small-cell lung cancer
41. Clinical courses of patients with small cell lung cancer after complete resection followed by adjuvant chemotherapy
42. In situ ultrasonic method for estimating residual tension of wedge fix type anchors
43. Efficacy and safety of epidermal growth factor receptor (EGFR) - Tyrosine kinase inhibitors (TKI) in elderly patients with EGFR mutation-positive non-small cell lung cancer (NSCLC)
44. Association of immune-related pneumonitis with the phenotypic appearance of concurrent ILD in patients treated with anti-PD-1 antibody
45. Relationships between lenvatinib plasma concentration and toxicity in Japanese cancer patients
46. Optimal interval from preceding radiotherapy (RT) to enhance efficacy of immune check point inhibitors (ICIs): Consecutive analysis of 294 patients with non-small cell lung cancer (NSCLC)
47. MASTER KEY project: A basket/umbrella trial for rare cancers in Japan
48. Phase I study of IDO1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with atezolizumab in Japanese patients with advanced solid tumors
49. A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease
50. Duct-penetrating method for pancreaticojejunostomy using a suture-assistance device around a non-dilated main pancreatic duct
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.